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Abstract
Medicare reimbursement rates across the United States have varied by as much as 49-130%
across healthcare facilities. Geographic adjustments and severity of medical diagnoses attribute
to some dissimilarity; however, the source of longer hospitalization and higher re-admission
rates among Medicare patients requires financial consistency. The research encompassed (N =
3000) patients with hypertension as the focus for the study because this is a critical group of
Medicare patients with a chronic disease that has been identified as a silent killer. The principal
goal that drove this research study was to explain the variations in length of stay for Medicare
patients with hypertension. The theoretical framework was the epidemiological triad model
composed of person, place, and time variables. A secondary data set was acquired from the
Healthcare Cost and Utilization Project Nationwide database of the National Inpatient Sample
for the duration of 2011 - 2013. A multiple logistic regression analysis was conducted to
determine if there was a correlation between length of stay and reimbursement rates for
hypertensive Medicare patients. The findings of this research study provided an analytical
explanation for the forces that have been driving Medicare patients’ LOS, and rate of
reimbursement. The research study yielded variations in the rate of reimbursement for a
government entity in medical charges by illustrating the utilization of geographic price
variations. The findings revealed that the categorical variable LOS and reimbursement rates for
Medicare hypertensive patients had a significant correlation, and with higher reimbursement
rates that were associated with longer hospital duration. The findings of the research study may
inform Medicare decision-makers to eliminate geographic price variation and provide greater
consistency in the rate of reimbursement, as well as a uniformity in length of stay across all
regions of the United States.
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Section 1: Introduction of the Study
Introduction
Medicare reimbursement rates are primarily regulated by the federal government and
receive further itemization per state. Respectively each Medicare reimbursement claim
undergoes a lengthy process prior to reimbursement of claims being compensated. This process
entails the coordination of benefits, coverage implication, billing, coding, denials, audits, and
appeals. Additionally, each itemized claim requires comprehensive detailed information per
patient and specific services rendered during the date(s) of service from the provider (Centers for
Medicare & Medicaid Services, 2017). Medicare reimbursement differs by state and is impacted
by the classification of reimbursement rate. Medicare reimbursement is comprised of eight
categorical rates that assist in medical coverage. These rates entail medical assistance, capitated,
critical access hospitals, federally qualified health centers, fee-for-services, Indian health service,
managed care organization, and Medicare waiver rates (Centers for Medicare & Medicaid
Services, 2017). An additional factor that contributes to Medicare reimbursement rate involves
geographic adjustments that are based on locality within rural regions of the United States, which
interpose a 5% to 10% increase above the national average (Centers for Medicare & Medicaid
Services, 2017).
The rate of Medicare reimbursement must adhere to federally legislated guidelines
despite variations among states to ensure corroborated payment parameters. These parameters
also dictate the payment rate for length of stay (LOS) per inpatient hospitalization or encounter
(Weiss & Elixhauser, 2012). Medicare Part A is the segment of Medicare that insures a patient’s
LOS for specific healthcare facilities such as acute care, critical access, inpatient rehabilitation,
and long-term care hospitals (Medicare.gov, 2017). From 2008 to 2012 the hospital inpatient
LOS for Medicare patients displayed an increase in aggregate hospital costs and a decrease in
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usage by Medicare patients (Weiss & Elixhauser, 2012). The LOS for Medicare recipients
decreased 1.9%between 2008 and 2012, whereas the cost gradually increased 0.7% over the
duration of 4 years. For Medicare recipients (65 years and older), the rate of hospitalization has
decreased nearly 4% for 4 consecutive years during the timeframe of 2008 to 2012 (Weiss &
Elixhauser, 2012).
Hypertension and the rate of Medicare reimbursement for the LOS have exhibited
variation from 2003 to 2012 with a decline in usage beginning in 2008 (Weiss & Elixhauser,
2012). In 2008 hypertension among Medicare patients was the most common comorbidity
accounting for 69% of the hospitalizations across the United States (Fraze, Jiang & Burgess,
2010). The average hospitalization cost per hypertensive Medicare patient annually was
$30,286, with an average LOS of 11 days in 2013; however, the average LOS for nongovernmental applied insurance had a higher average LOS of 28.5 days for the same timeframe
(Canavan, 2013). Medicare inpatient utilization management undergoes a process of applying
relative diagnosis related groups (DRGs) to further establish the necessity of hypertensive
Medicare patients LOS. The inpatient utilization management process may be a determining
factor in variations among Medicare beneficiaries and private insurance holders. The utilization
practice attempted to explain the stringent guidelines that healthcare organizations must adhere
to in applying DRG’s to re-admissions for hypertensive Medicare patients (Weiss & Elixhauser,
2012).
Variations among reimbursement rates for hypertensive Medicare beneficiaries and LOS
were expected to differ by state; however, establishing further understanding of the variation
within insurance providers required in depth exploration. Inpatient utilization of hypertensive
Medicare patients was recorded as costlier than commercially insured in 2011, showing a
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variation nearly $30,000 annually (Burke, Hunsche, Régulier, Nagao, Buzinec, & Drake, 2015).
In the research study, comparisons of variables utilized a multivariate analysis to assist in
determining elements associated with the LOS during hypertensive patient hospitalization
(American Psychological Association, 2012). A multivariate regression model assisted in
determining predictors in LOS, the relevance for Medicare reimbursement rates, and further
explained variations (Qureshi, et al, 2013). The analysis also attempted to assist in stabilizing
the pre-determined LOS for Medicare recipients.
Problem Statement
The source of longer lengths of hospital stay and extended hospitalization among
Medicare patients have not been fully understood. Patients with hypertension were chosen as the
focus for the study because this is a critical group of Medicare patients, and the logic of their
lengths of hospital stay, though previously explored, was not completely understood
(Medicaid.gov, 2016; Qureshi et al, 2013). The LOS for Medicare recipients were partially
predetermined by the rate of reimbursement as it pertained to each state. Due to variations
among states, there was no established rate of reimbursement per encounter for Medicare
patients (Cabin, Himmelstein, Siman & Woolhandler, 2014).
Some elements assisted in determining the rate of reimbursement per occurrence. These
included the medical condition (e.g., hypertension), the managed care organization’s
reimbursement rate, the fee-for-service rate, and Medicaid/Medicare waiver rates. Additional
factors that partially determined the LOS for Medicare patients included supplemental private
health, insurance, the state in which the hospital care was delivered, and the year in which the
patient was hospitalized (Medicaid.gov, 2016). These factors regulate the government outlier
strategies for cost-containment that govern the LOS reimbursement for Medicare patients

4
(Freitas, Silva-Costa, Lopes, Garcia-Lema, Teixeira-Pinto, Brazdil & Costa-Pereira, 2012).
Governmental regulations that determine reimbursement rates and LOS continue to vary
considerably and create variations depending on location, current reform, and organizational
dynamics (Kim, Kleerup, Ganz, Ponce, Lorenz & Needleman, 2015; Medicaid.gov, 2016).
Purpose of the Study
The principal goal that drove the research study was to explain the variations in LOS for
Medicare patients with hypertension (O'Brien, Xue, Ingersoll & Kelly, 2013). The knowledge
gap targeted by this study involved the mix of reimbursement rates that shortened lengths of stay,
thus containing costs for Medicare patients. Doing so required adjusting for the effects of
covariates. These included a common medical comorbidity (diabetes), gender, race or ethnicity,
year, and the region in which the care was provided (Cabin et al, 2014).
Research Questions and Hypotheses
RQ1: Are reimbursement rates related to the LOS for Medicare patients with
hypertension as the reason for admission after controlling for geographic region, age, year,
gender race/ethnicity, and diabetes?
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
H2: The hospital reimbursement rate is not related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
RQ2: Are the hospital reimbursement rates associated with prolonged hospitalization
for Medicare patients admitted for hypertension when controlling for geographic region, age,
year, gender, race/ethnicity, and diabetes?
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H3: The hospital reimbursement rate is associated with prolonged hospitalization for Medicare
patients with hypertension as the reason for admission when controlling for geographic region,
age, year, gender, race/ethnicity, and diabetes.
H4: The hospital reimbursement rate is not associated with prolonged hospitalization for
Medicare patients with hypertension as the reason for admission when controlling for geographic
region, age, year, gender, race/ethnicity, and diabetes.
Theoretical Framework
The theoretical framework for the research study was the epidemiological triad model
(Rohrer, Grover & Moats, 2013). The triad was composed of person, place, and time variables.
The triad model has been used in epidemiological investigation of disease outbreaks and has
been applied to hospital outcomes. This particular conceptual framework guided an
epidemiological exploration of variations in LOS and its association with triad variables (Centers
for Disease Control and Prevention.gov, 2017). The epidemiological triad model has been
successfully utilized by the World Health Organization (WHO) in determining influences such as
socio-economic, biological, and physical elements associated with infectious diseases, more
specifically in relation to the transmission of human immunodeficiency virus (HIV) within
specific locations (World Health Organization, 2014). The triad model factored in the host,
agent, and environment that identified intrinsic causes which had an affect the equilibrium of the
triad model. The agents were composed of biological, physical, mechanical components; while
the host consists of age, gender, ethnicity, customs, religion, and genetics. Lastly, the model
factors in environmental constituents which were comprised of physical, exposure, social, and
economic elements. Interaction between the three triad factors of the model illustrated causation,
and assisted in unearthing balance (Rohrer et al, 2013).
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Figure 1. Advanced model of the triangle of epidemiology. Adapted from Foundations of
Epidemiology (2nd ed. p. 14), by A.M. Lilienfeld and D.E. Lilienfeld, 1980, New York, NY:
Oxford University Press.
Significance of the Study
The findings of the research study provided an analytical explanation for the forces that
drove Medicare patients’ LOS. This study explained the logic behind costs applied for the
duration of hospitalization, in addition to delivering a foundation for policy reform by providing
analyzed data to Medicare and policy decision-makers to amend guidelines for reimbursement
rates and LOS (Ginsburg & Rivlin, 2015). The research is methodologically significant because
it employs current codes from the 10th revision of the International Statistical Classification of
Disease and Related Health Problems (ICD-10), which could result in higher accuracy of
medical diagnoses than was possible prior to ICD-10 (Medicaid.gov, 2016; Qureshi, Adil,
Zacharatos & Suri, 2013). The importance of the research is substantial, given its potential to
provide an explanation for trends in Medicare LOS as reported in previous Centers for Medicare
and Medicaid (CMS) documents (Maeda, Henke, Marder, Karaca, Friedman & Wong, 2014).
The study is significant for healthcare administrators because the findings may assist in
standardizing reimbursement rates for Medicare recipients without placing limitations on the
patients’ LOS, and may assist in improving patient outcomes. The research is also significant
because it provides further examination into the cost-shift theory for Medicare reimbursement
while simultaneously assisting in determining variations in current Medicare payment policies.
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These policies contain incentives for healthcare to optimize reimbursement that may lead to
efficient lengths of stay for Medicare recipients (White, 2013). The research study is also
significant because the results uncovered the logic behind particular Medicare states refusing to
cover extended LOS, while LOS and reimbursement rates in other states exhibit dramatic
dissimilarities. The research is meaningful due to the potential for revealing the rationale for a
government entity not being transparent across the board, as well as indicating whether there was
any improvement to decrease the fluctuations (Medicaid.gov, 2016).
Nature of the Study
The nature of the study involved quantitative methodology and cross-sectional design.
Medicare patients with hypertension who were hospitalized during the period between 2011 and
2013 were selected for analysis. A regression analysis was utilized to estimate the association
between the dependent variable, LOS, and reimbursement rates while controlling for covariates.
The analysis allowed the researcher to determine a relationship between the dependent variable
and the independent variables utilizing a multivariable logistic regression. The findings assisted
in reducing the gap in the literature regarding the determinants of Medicare lengths of stay
(Busby, Purdy & Hollingworth, 2015). Predictors of LOS for Medicare recipients with
hypertension were also identified. An epidemiologic triad approach guided the analysis by using
variables about person, place, and time (Rohrer, Grover & Moats, 2013).
Definition of Terms
The list below provides detailed definitions of terms utilized throughout the course of the
study.
Reimbursement rate: Term used for the payments that hospitals and physicians receive in
return for services rendered to Medicare beneficiaries (MedicareResources.org, 2015)
LOS (LOS): Term used to describe the duration of a single episode of hospitalization.
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Inpatient days are calculated by subtracting day of admission from day of discharge (Medical
Dictionary, 2017).
Blood pressure: Term used to describe two measurements of systolic and diastolic, blood
pressure is the force exerted by circulating blood on the walls of blood vessels and is an
important component of vital signs in human beings (Medical Dictionary, 2017).
Hypertension: Term used to define repeatedly elevated blood pressure exceeding 140
over 90 mmHg. A systolic pressure above 140 or a diastolic pressure over 90 (Medicinenet.com,
2017).
Borderline hypertension: Blood pressure measurement that lies between the highest
acceptable normal blood pressure and hypertensive blood pressure (Moser, 2007).
Chronic hypertension: Long term condition in which blood pressure is higher than
normal range blood pressure of 140/90 (Medical Dictionary, 2017).
Inpatient level of care: Term used to describe the intensity of medical care being
rendered by a physician or healthcare facility (Medical Dictionary, 2017).
Race: Refers to groups of people who have differences and similarities in biological
traits deemed by society to be socially significant, meaning that people treat other people
differently because of them (Merriam-Webster.com, 2017).
Ethnicity: The fact or state of belonging to a social group that has a common national or
cultural tradition. refers to shared cultural practices, perspectives, and distinctions that set apart
one group of people from another. That is, ethnicity is a shared cultural heritage (MerriamWebster.com, 2017).
Diagnosis-related group (DRG): A statistical method of classifying inpatient stays into
groups that assist in insurance compensation (Merriam-Webster.com, 2017).
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Centers for Medicare and Medicaid (CMS): A segment of the Department of Health and
Human Services (Centers for Medicare and Medicaid Services, 2017)
Medicare: A single-payer, national social insurance provider governed by the United
States government (Centers for Medicare and Medicaid Services, 2017)
Assumptions
The study was contingent upon identifying current data displaying variations among
reimbursement rates for Medicare hypertensive patient’s LOS. Dissimilarities were exhibited on
the region in which data is derived to express fluctuations in reimbursement rates for Medicare
recipients. The utilization of Medicare in conjunction with private insurance further provided
clarification in the differentiation of rates of Medicare reimbursement for hypertensive patients.
Significant governmental budgetary restraints within Medicare were vital factors in reduced LOS
(Ishak, Stolar, Hu, Alvarez, Wang, Getsios & Williams, 2012). Additionally, various elements
that contributed to hypertension among Medicare patients could not be gauged, such as patients
who are genetically prone to hypertension as well as diet, exercise, environmental factors,
lifestyle choices, and stress.
Scope and Delimitations
The researcher examined Medicare beneficiaries across the United States who were
medically diagnosed with hypertension. Medicare beneficiaries with hypertension were chosen
as a target population because hypertension continues to be the leading cause of chronic disease
commonly labeled as the silent killer (Grabowski, Huckfeldt, Sood, Escarce, & Newhouse,
2012). The research study incorporated a secondary dataset from Healthcare Cost and
Utilization Project (HCUP) nationwide database of the National Inpatient Sample (NIS) for 2011
to 2013. The research study was analyzed for the years 2011 to 2013 for the U.S. population.
Study outcomes have the potential to support greater consistency in LOS and reimbursement

10
rates for hypertensive Medicare beneficiaries as well as clarification while controlling for
geographic location, age, gender, year, race/ethnicity, and medical comorbidities. The research
study encompassed all Medicare beneficiaries including those who were categorized as
physically handicapped, and therefore qualified for Medicare benefits.
The previous sections of this study have provided an overview of problematic
implications of Medicare reimbursement and the LOS for hypertensive patients. It also presented
a relevant purpose of conducting a research aimed at presenting a social significance for a
targeted population utilizing a triad methodology. Section 1 has also imparted medical
terminology that was utilized throughout the course of the research study. Likewise, the research
questions and nature of the study have been presented to provide clarity concerning the basis of
the research with an epidemiological foundation.
A further in-depth analysis of the research questions and literature review addressing the
gap in literature was targeted in this study, and relevant social impacts on the Medicare
population. The literature review establishes a theoretical framework by utilizing a triad method,
indicates the need for research on LOS and reimbursement rates while recognizing aspects of
previous research studies on related topics. The literature review also identifies new techniques
for interpreting previous research, recognizes gaps within the literature, and justifies the need for
further research that specified a current timeline. Finally, the literature review identifies how
LOS and reimbursement rates have been researched, while providing interpretations of previous
and current material.
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Literature Review
Medicare was signed and implemented in 1965 by former president Lyndon B. Johnson.
Benefits for Medicare beneficiaries are initiated at the age of 65; however, beneficiaries may
enroll up to 3 months prior to their 65th birthday to ensure a timely enrollment (Centers for
Medicare & Medicaid Services, 2017). Establishing the rate of reimbursement and the LOS for
Medicare recipients required additional examination by region due to the variations within
Medicare policies. In accordance to each state, these variations produce distinctive differences
in healthcare coverage for LOS within each state due to state Medicare policies (Medicare.gov,
2017). Ongoing research has built on information provided by the Centers of Medicare and
Medicaid (CMS) to capture factors that contribute to the LOS. Some of the elements incorporate
medical diagnosis, morbidity, Medicare in conjunction with additional private insurance, and
participation of the provider. These factors which contribute to the LOS for Medicare recipients
have been explored to determine appropriate LOS (Qureshi, et al, 2013). Background
knowledge of reimbursement rates among Medicare recipients also took into account the total
fees associated with the LOS.
The differences in state Medicare policies were elements contributed to variations among
regions for LOS and expenses. The differences drove from hospitalization which were closely
associated elements that required closer assessment within the research study (Qureshi, et al,
2013). Analyzing data provided within the secondary data set had the potential to unveil the gap
of how certain components contribute to the LOS for person, timeframe, and location. The
research had the capability to acquire a better understanding of the reasoning for discrepancies in
the LOS for Medicare recipients (Qureshi, et al, 2013). The findings from previous research
studies pertaining to the association between LOS, and cost accrued has indicated that Medicare
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patients who were hospitalized for longer a duration have higher rates in the national estimates
with greater hospitalization charges (Busby, Purdy & Hollingworth, 2015).
These components had the potential to inform Medicare policy decision-makers to
become more cognizant of the variations in hospital charges and LOS for Medicare recipients
(Busby, et al, 2015). Likewise, further exploration may contribute to the overall health of the
Medicare hypertensive population by aiding in the decline of the national healthcare deficit
(McLaughlin & Olson, 2012). Further analysis of the research study likewise may assist in
identifying the elements of variation along with determining factors of extended hospital
duration. Additional research attempted to conclude the impact of hospital costs and LOS has on
the healthcare economy.
Strategies Used for Literature Review
The intention of the research study was to ascertain plausible explanations for variations
in reimbursement rates and LOS for hypertensive Medicare patients. Exploring online resources
that were peer-reviewed on BioMed Central, PubMed, government reports, literature matrix
(created by the researcher to enable quick comparisons among articles to determine the scope),
Google Scholar, and EBSCOhost will be utilized. Additional relevant resources utilized were
the Centers for Medicare & Medicaid (CMS), National Institute of Health (NIH), and evidence
table. Research articles that were relevant dating greater than five years were utilized merely for
the purpose of previous were established research. The terminology that was utilized to acquire
relevant literature were LOS, reimbursement rate, hypertension, supplemental private insurance,
hospital charges, admission, Medicare, inpatient management, mortality, CMS, DRG, and
variations.
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Gap Addressed
A review of related literature exploring the reimbursement rates and LOS for Medicare
patients disclosed the need for further research in determining the variations in LOS and
reimbursement rates. Variations in hospital charges across the United States were significantly
higher for private insurance providers as opposed to Medicare (Maeda et al, 2014). The
reimbursement rates factored in market-based tactics to ensure payment reform which assisted in
variations in reimbursement rates (Yoo et al, 2012). Additional research was conducted to
determine the LOS strategic guidelines to determine the reduction rate for Medicare patients
LOS (Martinez-Martinez et al, 2013). Additional factors that were associated with the LOS for
Medicare patients with hypertension entailed costs accompanied by comorbidities that increased
LOS, as well as admission and re-admission rates (Machnicki et al, 2011).
Demographics also influence the rate of reimbursement per region; however, determining
the calculations and guidelines that are applicable to Medicare patients remained to be
standardized across the United States for LOS (Busby et al, 2015; Ku-Chou et al, 2012). An
increased LOS additionally adds to outlier and costs associated with inpatient management;
therefore, driving the overall cost of inpatient stays beyond the estimated costs (Caravan, 2013;
Sawant et al, 2013). Over utilization of the emergency departments has warranted additional
research to explore per diem cost and LOS for hypertension and hypertension related illnesses
such as ischemic attacks, and vascular failure (Ishak et al; 2012; Singh et al, 2016). Previous
literature has not addressed the variables utilizing the triad approach in further determining the
reimbursement rates and LOS for hypertensive Medicare patients. The epidemiological
approach was suited to addressing the gap in literature, and providing knowledge of the process
utilized to govern reimbursement rates and LOS while imparting health care coverage.
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RQ1: Are reimbursement rates related to the LOS for Medicare patients with
hypertension as the reason for admission after controlling for geographic region, age, year,
gender race/ethnicity, and diabetes?
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
H2: The hospital reimbursement rate is not related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
RQ2: Are the hospital reimbursement rates associated with prolonged hospitalization
for Medicare patients admitted for hypertension when controlling for geographic region, age,
year, gender, race/ethnicity, and diabetes?
H3: The hospital reimbursement rate is associated with prolonged hospitalization for Medicare
patients with hypertension as the reason for admission when controlling for geographic region,
age, year, gender, race/ethnicity, and diabetes.
H4: The hospital reimbursement rate is not associated with prolonged hospitalization for
Medicare patients with hypertension as the reason for admission when controlling for geographic
region, age, year, gender, race/ethnicity, and diabetes.
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Table 2
Literature Matrix: LOS Results from Various Research Studies
Author/Year/Title

Sample

Variables

Maeda, et al, 2014
Variation in Hospital
Inpatient Prices Across
Small Geographic
Areas.

162
Counties
6 States

DV – Inpatient
pricing

Qureshi et al, 2013
Factors associated with
length of
hospitalization in
patients admitted with
transient ischemic
attack in United States

385

Mehta et al, 2016
Primary payer status,
individual patient
characteristics, and
hospital-level factors
affecting LOS and
total cost of
hospitalization in total
laryngectomy

4,128

IV –
Geographic
location

DV – LOS

Design

Findings

Multivariate
Analysis
Linear
Regression

Prices are significantly higher
for private vs. Medicare.
Payment policies from
Medicare affect private
payers. Public policy that
take into consideration
market-based approach or
payment reform to reduce
price variation

Multivariate
Analysis

Further strategies are required
to determine the reduction of
LOS

IV – Hospital
charges

DV – LOS

Multivariate
Analysis
IV – Total Cost Multi-linear
of
Regression
Hospitalization

The odds of being top
quartile of LOS for Medicaid
patients
by 41% compared to private
insured patients
After controlling for medical
factors Medicaid patients
had increased LOS
Overall cost was higher for
Medicaid and Medicare

Busby et al, 2015
A systematic review of
the magnitude and
cause of geographic
variation in unplanned
hospital admission
rates & LOS for
ambulatory care

43,819

DV – LOS
IV –
Admission
Rates

Crosssectional
Analysis

Wide variation in
admission rate
Fewer admission triggering
shorter LOS

(table continues)
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Yoo et al, 2012
Effect of
Reimbursement
Reductions on Bone
Mineral Density
Testing for Female
Medicare Beneficiaries

1,320

Ku-Chou et al, 2012
Prediction of LOS of
First-Ever Ischemic
Stroke

330

Martinez-Martinez et
al, 2013
Transient ischemic
attacks clinics provide
equivalent and more
efficient care than
early in-hospital
assessment

211

Machnicki et al, 2011
Kidney transplant
Medicare payments
and LOS: associations
with comorbidities and
organ quality

27,594

Burke et al, 2015
Characterizing
Pulmonary
Hypertension--Related
Hospitalization Costs
Among Medicare
Advantage

2,275

DVCox
Reimbursement proportional
Reduction
hazard
regression
IV –
analysis
Supplemental
private health
insurance

Significant association
between reimbursement
reductions and decrease in
BMD test in female
Medicare beneficiaries
without supplemental
private insurance

DV- LOS
IV – clinical
predictors

Univariate
Analysis and
Multiple
Regression
Analysis

Severity of stroke revealed to
be a vital factor that
influences the LOS after a
cute stroke hospitalization

DV – Inpatient
Management

Logistic
regression

Transient ischemic attacks
clinics are efficient for the
early management of low- to
moderate-risk TIA patients
compared to in-hospital
assessment, with no higher
recurrence rates and at almost
one-fifth the cost.

Multi-linear
regression

Impact of comorbidities on
reimbursement, LOS and
transplant finances depend on
local practice, outcomes and
reimbursement system.
Further studies should be
conducted to confirm
associations and design
appropriate interventions

IV – Cost per
patient

DV- LOS
IV – Medicare
Payments

DVLinear
Readmission of regression
pulmonary
hypertension
hospitalization
IV – premature
mortality

PH-related hospitalizations
incur substantial healthcare
costs and require long
hospital stays for patients
with PAH. Improved
treatment approaches reduce
PAH disease progression
leading to costly and
burdensome inpatient stays
(table continues)
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Ishak et al, 2012
Accounting for the
relationship between
per diem cost and LOS
when estimating
hospitalization costs

11,614

Canavan, 2013
Rehospitalization Is
Driving Costs in
Pulmonary Arterial
Hypertension

4,009

Sawant et al, 2013
Increased LOS and
costs associated with
inpatient management
of vascular access
failures

Singh et al, 2016
Emergency
Department and
Inpatient Healthcare
utilization due to
Hypertension.

DV- LOS

Linear
regression

Per diem costs are not
independent of LOS

Linear
regression

Overall, PAH who were
hospitalized during the study
period from January 2007
through December 2011,
39.2% were re-hospitalized
more than once.

Logistic
regression
analysis

Vascular access management
contributes to signiﬁcant
expenses especially during
ﬁrst few months of initiation
of dialysis. This increases
workload on the already
overburdened hospital
infrastructure and draws
up costs and increases length
of stay

Multivariableadjusted linear
or logistic
regression

Hypertension associated with
significant healthcare burden
in the U.S. Future studies
should assess strategies to
reduce hypertension-associated
cost and healthcare burden

Logistic
regression

The pattern of higher
healthcare utilization among
MA patients persists even
after controlling for baseline
health conditions

IV – Per Diem
Costs

DV – LOS
IV –
Hospitalization
Costs

172

DV – LOS
IV - Costs

2,934,838 DV –
Hospitalization
outcomes
(LOS, charges,
disposition)
IVHypertension
associated ED

Suh et al, 2014
Effect of health
insurance type on
healthcare utilization
in patients with
hypertension: a
national health
insurance database

325,566

DV – LOS
IV –
Hospitalization
Costs
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Medicare Hospitalization Cost
Hospital charges accrued by Medicare patients are estimated total payment amounts that
encompass the diagnosis related group (DRG) cost, total charge per diem, Medicare primary
payer cost, coinsurance, deductible, and DRG outlier total (Centers for Medicare & Medicaid
Services, 2017). CMS utilized data on hospital-specific expenses for over 3,000 hospitals
nationally. Each healthcare facility applied government specified Medicare Severity Diagnosis
Related Group (MS-DRG) annually to itemize services rendered to Medicare patients. Nearly
75% of Medicare discharges were represented by the MS-DRG which accounts for more than 7
million inpatient prospective payment system (IPPS) discharges (Centers for Medicare &
Medicaid Services, 2017). Medicare likewise applied supplemental payments to the healthcare
facilities commonly known as outlier payments which were formulated to safeguard against
substantial economic loss.
Medicare Payment
Medicare reimbursements for hypertensive patients are categorized into groups
determined by payer status such as denials (i.e., medically unnecessary or non-covered
care/patient), delays (i.e. additional review required), and payments forthcoming (Mehta, Flores,
Thompson, & Nathan, 2016). Payment validation within each healthcare organization entails
eligibility verification, metrics, benchmarking, and cost methodology in an effort to remain
within a model of care and reimbursement. Billing and coding for Medicare reimbursement
involves five-digit current procedural terminology (CPT) and modifiers for appropriate coding
which also permit accuracy (Medicare.gov, 2017). Reimbursement expectations vary depending
on the appropriate charge capture, coding and claims submission that each healthcare facility
submits to Medicare by accepting applicable billing. Each Medicare claim presented by a
healthcare provider is obligated to be under government compliance to ensure an operational
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revenue cycle. The utilization of DRG coding and current ICD-10 compliance are more efficient
means of providing a specific charge structure due to the capability of the process to deliver
accuracy and compliance solutions (Medicare.gov, 2017). Reimbursement and revenue cycle
optimization for Medicare patients are continuously undergoing procedures that should minimize
denied and delayed compensation. Rejection resolutions for payment posting and denial analysis
are predetermined by traditional and current coding practices that are in conjunction with
regulatory compliance. As compensation for medical care is acquired, many healthcare
organizations are contracted to utilize a process termed super billing (charges completed by
provider) in an effort to obtain expedited payment (Medicare.gov, 2017).
Demographics and clinical predictors contribute to LOS for Medicare patients depending
on the state and local parameters established in outlier assessments. Regional specifications may
likewise interject the rate of admissions, and readmissions for predictors such as hypertension,
gender, age, and race/ethnicity (Chang, Tseng, Weng, Lin, Liou, Teng-Yeow & Tan, 2002).
Influential factors in the rate of Medicare reimbursement operate in conjunction with recurrent
cost analysis to alleviate intermittent and distinct variations.
Although consistency is an imminent segment of Medicare reimbursement; elements such
as location and medical severity greatly influence general revenue cycle components (Chang et
al, 2002). Demographic and medical characteristics of patients whose LOS was assessed
disclosed that the median for age was 66 of which 58.5% were men and 41.5% women (Chang,
Tseng, Weng, Lin, Liou, Teng-Yeow & Tan, 2002). The median LOS was 7 days, which also
encompassed other variables such as smoking, stroke, severity of stroke, neurological
impairments, and LOS post-acute hospitalization (Chang et al, 2002).
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Pulmonary hypertension (PH) fees for Medicare patients incurred significant costs due to
readmissions, and required a longer duration of hospitalization. Many PH patients often
encounter a higher readmission rate within 1-year due to the chronic pulmonary disease
encountering many complications (Burke et al, 2015). The average cost for Medicare patient
hospitalization from PH was just over $46,000 in 2011 with the average LOS was approximately
11 days. The cost and LOS for admission were significantly higher for Medicare versus
commercially insurance with the difference being just under $20,000 per year, and with a fourday variation in LOS (Burke et al, 2015).
From 1989 to 2014, the rate of Medicare spending increased approximately 5.5% per
year, placing it at a rate 6.3% behind the annual rate of commercial insurance per person.
Additionally, from 2010-2015 the spending rates were somewhat analogous for Medicare, and
commercial insurance with an annual increase of only 1.4% over the duration of a six-year time
frame (Cubanski & Neuman, 2016). The projected spending expenditure for Medicare between
2015 and 2025 is 7.1% which is a 4.4% gain for the annual growth between 2010 and 2015
(Cubanski & Neuman, 2016).
Supplemental Private Insurance
Supplemental insurance in conjunction with Medicare coverage provides patients with a
broader range of medical coverage, and places the provider at a higher rate of reimbursement
with the dual coverage. Medicare revenue is provided by numerous sources such as general
revenue, payroll taxes, beneficiary premium, social security taxation, interest, and state payments
(Medicare.gov, 2017). Medicare supplemental insurance (Medigap) provides Medicare patients
with additional coverage that encompasses copays, coinsurance, and deductibles (Medicare.gov,
2017).
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Average Annual Percentage Growth Rates in
Medicare and Private Health Insurance
Spending, 2000-2015
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Figure 2. Average annual growth rate percentage in Medicare and private health insurance
spending, 2000-2015, by Kaiser Family Foundation.
Source: Cubanski & Neuman, The Facts on Medicare Spending and Financing. Kaiser Family
Foundation analysis of Medicare spending data from Boards of Trustees; private health insurance
spending data from the CMS National Health Expenditures data.
The Medicare annual growth rate and private health insurance indicated a decrease from
2010-2015 as opposed to 2000-2010 (Cubanski & Neuman, 2016). Primary insurance principal
purpose is to provide reimbursement first, and the beneficiary will be responsible for the
remainder of costs incurred. Secondary insurance provides reimbursement for a portion or the
remainder of the cost after primary insurance has been compensated. Medicare beneficiaries
that possess both primary and secondary insurance coverage with one being private insurance
have the option to enroll in Medicare Part A. Medicare Part A utilized in conjunction with
private insurance provides the beneficiary with medical coverage either free of charge or with a
low premium and no out-of-pocket limitation (Medicare.gov, 2017). Additional Medicare
coverage such as Part B can be applied as a secondary insurance for beneficiaries in conjunction
with health insurance from an employer.
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Projected Average Annual Percentage Growth
Rate in Medicare and Private Health Insurance
Spending, 2015-2025
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Figure 3. Projected average annual percentage growth rate in Medicare and private health
insurance spending, 2000-2015 by Kaiser Family Foundation.
Source: Cubanski & Neuman, The Facts on Medicare Spending and Financing. Kaiser Family
Foundation analysis of Medicare spending data from Boards of Trustees; private health insurance
spending data from the CMS National Health Expenditures data.
Enhanced management for Medicare patients such as age and health specified treatment
have the capability to assist in progression toward a reduction of exorbitant and onerous LOS
(Burke et al, 2015). Medicare and primary health insurance spending that operates collectively
possess a greater chance of claims being reimbursed; however, the total Medicare spending far
exceeds private health insurance per capita while there is only a marginal difference in Medicare
and PHI per capita (Cubanski & Neuman, 2016). Controlling for Medicare costs can be taxing;
however, when additional healthcare coverage is applied such as Medigap, TRICARE, long-term
care insurance, the Federal Employees Health Benefits Program (FEHBP), and American
Association of Retired Persons (AARP) expenditures can be curtailed. The type of insurance has
an influence on patient frequency, resources, preventative utilization, and more explicitly on
LOS (Suh, Kang, Kim & Shin, 2014).
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Reimbursement Rate
The rate of Medicare reimbursement heavily relies on funding from the federal
government and states (Medicare Resources, 2012). The Medicare-to-Medicare fee gauges a
healthcare organization fees within each state, and adjusts reimbursement rates accordingly per
service state or region (Medicaid.gov, 2017). The Medicare fee schedule is comprised of
itemized fees utilized to reimburse providers, and provide a fee maximum for the services
rendered. The services rendered may include laboratory services, durable medical equipment
(DME), ambulatory services, primary care services, hospitalization, and much more that are all
assessed with the Medicare fee schedule (Medicaid.gov, 2017).
The Medicare fee schedule and hospital LOS outlier management process administers
particular guidelines to financing within a healthcare system. During the process of healthcare
administration and Medicare outlier consulting, it is determined the maximum LOS for Medicare
patients will be accordance to the medical diagnosis (Freitas, Silva-Costa, Lopes, Garcia-Lema,
Teixeira-Pinto, Brazdil & Costa-Pereira, 2012; Medicare.gov, 2017). Nearly 4.0% of high LOS
outliers accounted for 19.2% of total hospitalization with academic hospitals having a longer
LOS and readmissions (Freitas et al, 2012).
Inpatient Pricing
Inpatient pricing is contingent on the complexity of the healthcare organization and a
patient’s medical diagnosis as well as the determinant of LOS (Maeda, Henke, Marder, Karaca,
Friedman & Wong, 2014). A patient’s intricate diagnosis is assessed by medical professionals
and administration to ensure that the Medicare guidelines are taken into consideration when
applying hospital pricing. Likewise, consideration is applied to the costs that will vary
systematically with the determined LOS, location, and the complexity of a patient’s medical
condition (Ishak et al, 2012).
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Length of Stay
The LOS for Medicare patients is determined by the medical diagnosis, DRG,
demographics, and government guidelines that are applicable to each healthcare organization.
The duration for patient stay is categorized into the average LOS and the geometric LOS. The
difference between the average LOS and geometric mean LOS is that the average LOS is the
calculations a hospital defines as the duration a patient stays within an occurrence during
hospitalization (Freitas et al, 2012). The average LOS is also analyzed by the number of patients
with similar/same diagnosis with a LOS divided by the total number of patients admitted over
the past 12 months. Whereas, the geometric mean LOS is a computed by multiplying all of the
LOS and using the nth root of the number of patients (Freitas et al, 2012).
Admission Rate
The admission rate is constantly rising due to the age of Medicare beneficiaries, and the
ongoing medical conditions associated with an aging or physically handicap population
(Canavan, 2013). Current trends in hypertensive patients are often coupled with other chronic
illnesses such as diabetes, kidney failure, and cardiovascular disease (Lipska, Ross, Wang,
Inzucchi, Minges, Karter, Huang, Desai, Gill, Krumholz, 2014). These illnesses have directly
impacted the rate in which Medicare patients are hospitalized and treated in an effort to
effectively care for older adults or the physically disabled (Busby, Purdy & Hollingworth, 2015).
Additionally, the LOS is influenced by admission rate as well as the readmission of hypertensive
patients with combined sickness. Hospitalization costs and LOS for hypertensive patients with
pulmonary arterial hypertension estimated just over $30,000 with the average LOS of 11 days.
The total costs for patients that were readmitted was approximately $71,000 with a LOS of 24.5
days (Canavan, 2013).
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Readmission Rate
The readmission rate of hypertensive Medicare patients is calculated by estimating the
number of patients who return for the same diagnosis within 30 days of the previous discharge.
The readmission rate can be further examined by age, gender, and demographic location
(Dartmouthatlas.org, 2017). This data provides detailed reimbursement rates for hospital
admission and readmission for various healthcare facilities such as skilled nursing facilities and
outpatient establishments for reimbursement rates on behalf of the health services rendered.
Currently, healthcare organizations with low inpatient admission rates are commonly
located within rural regions; however, these regions have been recorded as having lower rates of
mortality (Minemyer, 2017). The mortality rate for Medicare patients that were discharges
within seven days was 0.12%, which contributed to approximately 10,000 unexpected deaths
annually (Minemyer, 2017). Hospitals with higher admission rates which discharged nearly 85%
of Medicare patients incurred a death rate of 3.4% higher than healthcare organizations with a
lower admission rate (Qureshi, Adil, Zacharatos & Suri, 2013).
Inpatient Management
Since 2012 there has been a nationwide decline in the admission and readmission rates
for Medicare patients. This decrease may be a direct result of a plethora of healthcare process
improvement techniques, and quality of care initiatives that have been implemented within many
healthcare organizations (Martínez-Martínez, Martínez-Sánchez, Fuentes, Cazorla-García, RuizAres, Correas-Callero, Lara-Lara & Díez-Tejedor, 2013; McLaughlin & Olson, 2012). A more
comprehensive exploration for the decline in readmission still requires further investigation
(Sawant, Mills & Dhingra, 2013). The number of Medicare admissions has decreased from 11.4
million in 2007 to 10.4 million in 2012, and readmission rate from 2.1 million in 2007 to 1.9
million in 2012 (Gerhardt, Yemane, Apostle, Oelschlaeger, Rollins, Brennan, 2014)
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Geographic Factors
Geographic elements consistently have an effect on the rate of Medicare reimbursement,
mortality, LOS, admission, and readmission rates. Medicare geographic adjustment factors have
been utilized in an effort to ensure that healthcare providers and healthcare organizations are
reimbursed sufficient payment for the care provided (Geographic Adjustment Factors in
Medicare Payments, 2011). Some geographic factors also consist of adjustments of fee-forservice reimbursement rates in accordance to geographic location to control variations among
rural and metropolitan regions. The adjustments attempt to assist in providing reimbursements
that reflect on local costs of rendering care. This process aids in ensuring that Medicare provides
adequate payment per region according to the geographic practice cost index (Edmunds & Sloan,
2011).
In an effort to enhance accuracy in geographic adjustments, Medicare attempts to gauge
reimbursement according to the local labor market, in which healthcare providers manage and
contend for employees (Busby, Purdy & Hollingworth, 2015). With the utilization of labor
market data, Medicare can make certain that broadening healthcare providers to be incorporated
in computing a wage index, and fluctuations in pricing (Edmunds & Sloan, 2011). The
fluctuation in pricing per region may directly impact the rate of reimbursement, and the LOS
when healthcare organizations are striving to adhere to Medicare guidelines. A conceptual
rationale for utilizing data from a healthcare sectors versus industry-wide can assist in improving
accuracy in geographic adjustments and address concerns conveyed by stakeholders. The
Institute of Medicine (IOM) evaluates the accuracy of geographic adjustments factors,
methodology, data, and the effects adjustments have on Medicare reimbursement rates. The
evaluations assist in the quality of care, higher rate of reimbursements, and overall health of the
populations (Maeda et al, 2014).
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Hypertension
Medicare patients who have been diagnosed with hypertension can be covered under
Medicare Part B and D. Medicare covers patients for screening that assist in alleviating stroke
which may be directly caused from hypertension prevalence (Medicare.gov, 2017).
Hypertensive patients account for nearly 70 million people across the U.S., and over $42.9
billion was spent in 2010 to treat hypertensive patients. Approximately 1 in every 3 adults is
clinically diagnosed with hypertension, and the prevalence increases with an aging population
(CMS.gov, 2017). Within the age range of 18 to 39 nearly 7% of the population is diagnosed
with hypertension, while there is nearly 67% with hypertension over the age of 60. Hypertension
is the leading cause of chronic disease mortality in the U.S. due to uncontrolled high blood
pressure resulting in approximately 1,000 deaths daily (CMS.gov, 2017).
Table 1
Classification of Hypertension
___________________________________________________________________
Blood Pressure
Systolic Blood Pressure
Diastolic Blood Pressure
Classification
(SBP) – mmHG
(DBP) – mmHG
____________________________________________________________________
Normal
<120
<80
Pre-hypertensive
120-139
80-89
Stage 1 Hypertension
140-159
90-99
Stage 2 Hypertension
>160
>100
____________________________________________________________________
Note. 2004 Joint National Committee on Prevention, Detection, Evaluation & Treatment
of High Blood Pressure. Source: National Heart, Lung, and Blood Institute (NHLBI),
National Institutes of Health. http://www.nhlbi.nih.gov/guidelines/hypertension
Hypertension accounted for nearly 55% of Medicare fee-for-service in 2012. The
disparities associated with elderly hypertension were among the highest in the African-American
population at 63%, followed by 56% in the Asian/Pacific Islander community, and 55% of NonHispanic/whites (CMS.gov, 2017)
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Figure 4
Source: Centers for Medicare & Medicaid Services. Chronic Condition Data Warehouse (CCW)
Centers for Disease Control and Prevention. Hypertension among Adults in the United States:
National Health and Nutrition Examination Survey, 2011-2012.
Centers for Medicare & Medicaid Services. Chronic Conditions.
Despite the plethora of medications and treatments to combat hypertension, high blood
pressure still remains to be fully controlled or eradicated among Medicare patients. Some
factors that accompany prevalence with the Medicare population are non-adherence to prescribed
treatment, patients who are genetically pre-disposed to hypertension, lack of awareness that the
chronic disease exists due to insufficient treatment, socio-demographic, and clinical
characteristics (CMS.gov, 2017). Hypertension prevalence that addresses the variation in
clinically diagnosed Medicare patients among socio-demographics has the capability to
strengthen regulations associated to quality of care as well as assist in providing standardization
in LOS, admission, and reimbursement rates. By applying industry wide consistency, Medicare
policies have the potential to employ quality measures in an effort to develop regulated
specifications across the healthcare continuum (Mastragelo, 2014).
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Hypertension Mortality
Hypertension among Medicare patients is commonly accompanied with other chronic
diseases such as diabetes, ischemic heart disease, high cholesterol, renal failure, stroke, arthritis,
and dementia (Moser, 2007). The most prevalence triad chronic condition combination is
ischemic heart disease, hypertension, and diabetes with 33.7% prevalence. This triad has a per
capita spending expenditure of nearly $20,000 per patients; however, the most costly triad is
stroke, chronic kidney disease, and asthma (Semilla, Chen, Dall, 2015).
The reduction in mortality rate among Medicare patients post implementation of
Medicare Part D assisted in the reduction of deaths by 2.2% annually. Medicare Part D
enhanced drug coverage which aided in comprehensive coverage, and increased utilization of
hypertensive medication with treatment. Since the implementation of Part D, approximately
200,000 Medicare beneficiaries have increased longevity by an average of 3 years (CMS.gov,
21017).
Hypertension mortality and geographic variations are consistent in LOS; furthermore,
placing a higher mortality rate in rural regions. The rate of hypertension mortality during readmission was decreased by 4% in 2013 as opposed to 1% for initial hospitalization (Freeman,
Wang, Akar, Desai, Krumholz, 2017). In 2013 Medicare fee-for-service patients who were
admitted and treated with more cost consuming treatments; however, the quality of care rendered
results greater than 30-day readmissions with a lower mortality rate (Freeman et al, 2017).
Hypertension ED Utilization
Utilization of the emergency department (ED) and inpatient health services for
hypertension related occurrences within the United States has increased since 2009 from 920,984
to 1,041,233 for patients with hypertension as the primary diagnosis (Singh & Yu, 2016).
Hypertension is medically described as blood pressure measuring greater than 140/90 mm Hg
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(Williams, 2012). Of the over one million hypertension related visits to the ED, 23% of the
patients were hospitalized for further monitoring, testing, and treatment. During the course of
the last four years there has been a 13% upsurge in ED utilization for hypertension documented
cases that has added to national health care deficit (Singh & Yu, 2016). One in seven adults
classified as hypertensive that utilizes the ED is uninsured, which is estimated at 4 million
nationwide (Brooks, 2016). Approximately 15% of hypertensive related visits to the ED were by
those who were uninsured and an addition 23.4% utilized Medicaid (Centers for Disease Control
and Prevention.gov, 2015). The individuals who received Medicaid coverage were more likely
to utilize the ED than those who had private insurance (Centers for Disease Control and
Prevention.gov, 2015). Despite the plethora of medical therapy for hypertension treatment and
monitoring, it remains an inadequate system for cost-containment within the U.S., thus creating a
negative impact on the health care economy (Centers for Disease Control and Prevention.gov,
2015). Of the ED visits due to hypertension associated instances 11% of patients were
hospitalized and an additional 13% transferred to other health care facilities (Singh & Yu, 2016).
Nearly 18% of uninsured hypertensive patients neglected visits to a primary care physician, and
thus utilized the ED as means of primary care treatment (Brookes, 2016).
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Figure 5
Source: (Centers for Disease Control and Prevention.gov, 2015)
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Summary
The reimbursement rate for hypertensive patients receiving Medicare benefits varied
depending on a number of factors as explored within the literature review. These variations were
comprised of several components that assisted a geographic region in reducing readmissions,
assigning the appropriate LOS, and adequate reimbursement rate per location. Medicare
guidelines are practiced in accordance to state and governmental regulations; however, the
guidelines were not consistent across all states. Geographic adjustments are one of the many
reasons that reimbursement variations occur with specified regions (Geographic Adjustment
Factors in Medicare Payments, 2011).
Additional insurance utilized in conjunction with Medicare supplemental (Medigap)
offered beneficiaries with a broader range of coverage and alleviates the responsibility of
disbursing out-of-pocket funds (Medicare.gov, 2017). Approximately 4.0% of high LOS
outliers accounted for 19.2% of extended stay which caused a longer LOS and a greater
probability for readmissions (Freitas et al, 2012). Healthcare facilities with high admission rates
discharged nearly 85% of Medicare patients triggering a death rate of 3.4% higher than hospitals
with a low admission rate for hypertensive patients (Qureshi, Adil, Zacharatos & Suri, 2013).
The literature review focused on exploring reasoning for variations per geographic region
and the LOS for Medicare hypertensive patients. The literature also exhibited factors of
Medicare that have implications on healthcare costs such as prevalent chronic diseases that are
expressed in an aging population as well as groups (ethnic/race, gender, region) that were
impacted by hypertension. The variations in acceptable LOS per region also had an influence of
the rate of reimbursement on behalf of Medicare beneficiaries. Likewise, the utilization of the
ED interjected and is an initial dynamic in the LOS along with admission or readmission.
Minimizing the use of the ED, and interchanging activity with routine office visits may alleviate
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additional costs. The significance of the research may provide rationale for a government entity
consistency nationwide, and whether there has been any improvement to decrease the
fluctuations (Medicaid.gov, 2016). The need for further research is based upon further strategies
that are required to determine the reduction of LOS, the significant price variation in Medicare
and private insurance, the demand for a market-based approach or payment reform, and
additional research pertaining to the impact of comorbidities on reimbursement and LOS as a
U.S. healthcare burden (Qureshi et al, 2013). Furthermore, seeking determinants of extended
hospitalization and concluding the effect on costs that impacted the LOS for Medicare patients
nationwide are gaps that were explored.
The research had the capability to provide a positive social impact by providing new
reimbursement standards that will benefit Medicare recipients. Likewise, with enhanced
guidelines implemented by Medicare it had the potential to require flexibility in reimbursement
for treatment surrounding hypertension, and gauging the essentials for targeted populations
which may increase the rate of reimbursement (Suh et al, 2016). Strengths within the research
unveiled the need for maximizing the LOS allotted by healthcare organization and Medicare
reimbursement guidelines in an effort to become more cost efficient while meeting the healthcare
needs of the population. However, the drawback of maximizing the LOS for hypertensive
patients may contribute to the already rising deficit of the healthcare economy nationwide.
Increased LOS may also place a strain on the rate of reimbursement considering there was a flat
fee rate for the services rendered despite the increasing number of Medicare patients with
chronic diseases. An opportunity presented was the possibility of increased reimbursements and
extended LOS for patients with medical necessity; however, the threats of encompassed the
validity of the rates of reimbursement and variations pertaining to demographic regions.
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Section 2: Research Method
Introduction
The research method that was applied to assess the hypothesis was a quantitative
multivariate analysis. The logistic regression analysis testing determined that there was a direct
correlation in hospital reimbursement rates being associated with prolonged hospitalization
and/or reimbursement rates related to the LOS for Medicare patients with hypertension. This
section presented the research methodology, setting, size, region, target population, instruments
and materials utilized to assist in the analysis. Multiple studies were explored that were
comparable and consistent in controlling for similar covariates, LOS and reimbursement rates for
Medicare patients with hypertension.
Research Design
A logistic research design was applied to the study to present correlation between
variables as well as an epidemiological model consisting of person, place, and time. A
quantitative design assisted in identifying the extent of the correlation and factors within the
target population. A quantitative analysis verified the data presented via the use of statistical
package for the social sciences (SPSS). The design assisted in determining trends within
Medicare reimbursement rates and LOS factors associated with hypertensive patients. The
research design likewise assisted in quantifying data from the target population, and measuring
the incidence from multiple aspects within the sample including exploring additional findings.
The quantitative research was utilized in determining variations in reimbursement rates and LOS
by the region in which Medicare benefits were applied. It also explored applicable results that
were utilized in creating positive social change within the target population.
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Methodology
Setting and Sample
Data were analyzed that represented of hypertensive patients who had received Medicare
benefits from 2011 to 2013. A secondary data set that was utilized in the research study was
acquired from the Healthcare Cost and Utilization Project (HCUP) nationwide database of the
National Inpatient Sample (NIS) for the duration of 2011 - 2013. In conjunction with the
secondary data set supplied by HCUP-NIS examination of the reimbursement rates for LOS for
Medicare patients was used while simultaneously controlling for covariates categorized from the
secondary data set (Qureshi, et al, 2013). To obtain secondary data from HCUP, a mandatory
data use agreement course was completed that addressed the key aspects of utilizing secondary
from the HCUP website (Agency for Healthcare Research and Quality, 2016). A certificate code
was then issued to access the secondary dataset electronically, and provided authorization for
utilizing data to conduct testing for the research setting that concentrated on the U.S. population
of hypertensive Medicare patients.
Target Population
The research focused on Medicare recipients who were medically diagnosed as
hypertensive. The inclusion of hypertensive Medicare patients was necessary in order to assess
the hypothesis, and determine whether there was a correlation among reimbursement rates and
LOS for hypertensive patients. Patients who were not medically diagnosed with hypertension or
receiving Medicare benefits were excluded from the research study. The research did not
exclude patients based upon location, gender, ethnicity/race, age, physical disability, or preexisting comorbidities, but rather utilized the covariates to determine additional factors that
exhibited variations.
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Data Analysis
The statistical analysis was composed of a descriptive, a two-way test of association,
followed by multivariate logistic regression to address Research Question 1, and logistic
regression to address Research Question 2. Categorical variables were analyzed to determine the
percentage of male and female subjects as well as to define race/ethnicity in each category.
Further analysis assisted in defining the number of subjects by medical comorbidity and year.
The mean, mode, and standard deviation were calculated per category to exhibit variations per
year. The research analyses likewise assisted in establishing a high or low rate of
reimbursement, and determining the average LOS for Medicare patients with hypertensions. The
covariates were analyzed to determine the significance in variations.
Power Analysis
Sample Size: X-Sectional, Cohort, & Randomized Clinical Trials
Two-sided significance level(1-alpha):
95
Power(1-beta, % chance of detecting):
80
Ratio of sample size, Unexposed/Exposed:
3
Percent of Unexposed with Outcome:
50
Percent of Exposed with Outcome:
67
Odds Ratio:
2
Risk/Prevalence Ratio:
1.3
Risk/Prevalence difference:
17
Kelsey

Fleiss

Fleiss with CC

Sample Size - Exposed

94

92

100

Sample Size-Nonexposed

281

275

298

Total sample size:

375

367

398

References
Figure 6
Kelsey et al., Methods in Observational Epidemiology 2nd Edition, Table 12-15
Fleiss, Statistical Methods for Rates and Proportions, formulas 3.18 &3.19
CC = continuity correction
Results are rounded up to the nearest integer.
Results from OpenEpi, Version 3, open source calculator--SSCohort
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The power analysis was calculated with the utilization of Open Source Epidemiologic
Statistics for Public Health, Version 2.3.1 (Open Source Epidemiologic Statistic for Public
Health, 2013). The power analysis calculations for sample size yielded a minimum of 398 for
the research study, given a beta of 80% which provided a high enough effect volume for
determining the LOS and reimbursement rate for Medicare patients with hypertension. The
estimated confidence level, power, odds ratio, ratio of unexposed to exposed, and percentage of
unexposed with outcome were calculated to assist in determining an effective sample size for the
research study by utilizing the sample cohort and randomized clinical trial study calculations
provided by Open Source Epidemiologic Statistics for Public Health.
Instruments and Materials
The Healthcare Cost and Utilization Project (HCUP) nationwide database of the National
Inpatient Sample (NIS) database that encompassed a secondary dataset from 2011 to 2013 was
utilized. The secondary dataset encompassed patients as the unit of analysis, and provided data
for the dependent and independent variables that were analyzed. SPSS was the statistical tool
utilized to measure the data by applying a logistic regression analysis. Upon receiving
calculations post logistic regression analysis and descriptive statistic assisted in analyzing the
data within SPSS, and interpretation aided in determining a null or alternative hypothesis.
The dependent variable, LOS was analyzed in conjunction with the independent variable
of reimbursement rate. The covariates within the research were age, gender, location, timeframe
in which services were rendered ethnicity/race, and diabetes. The location of the research was
limited to United States, and the ethnicities represented included White, Asian/Pacific Islander,
Black/African-American, Hispanic, and other to encompass smaller groups. The timeframe for
the research included 4 consecutive years of data to exhibit a current study aimed at exploring
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the gap in literature as well as current and past findings pertaining to the LOS. The secondary
dataset was tested against the following research study questions:
RQ1 – Are reimbursement rates related to the LOS for Medicare patients with hypertension as
the reason for admission after controlling for state, age, year, gender race/ethnicity, and diabetes?
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for state, age, year, gender,
race/ethnicity, and diabetes.
H2: The hospital reimbursement rate is not related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for state, age, year, gender,
race/ethnicity, and diabetes.
RQ2 – Are the hospital reimbursement rates associated with prolonged hospitalization for
Medicare patients admitted for hypertension when controlling for state, age, year, gender,
race/ethnicity, and diabetes?
H3: The hospital reimbursement rate is associated with prolonged hospitalization for Medicare
patients with hypertension as the reason for admission when controlling for state, age, year,
gender, race/ethnicity, and diabetes.
H4: The hospital reimbursement rate is associated with prolonged hospitalization for Medicare
patients with hypertension as the reason for admission when controlling for state, age, year,
gender, race/ethnicity, and diabetes.
Data Protection and Privacy
The research study underwent the approval process of the Walden University Institutional
Review Board (IRB) to utilize an external secondary dataset. The Data Protection Act 1998 was
defined for processing data on patients that are identifiable for living individuals. (Personal Data
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Protection Commission, 2017). This act protects individuals from being exploited and private
information from unsolicited distribution. This data protection act was also applied to ensure
that Protected Health Information (PHI) was safeguarded and provided individuals with an array
of privacy rights. The PHI rights however permit the disclosure of data required for quality of
patient of care and necessary documentation for verification. PHI also works in conjunction with
the Health Insurance Portability and Accountability Act (HIPAA) to ensure patient
confidentiality in relation to electronic or hardcopy data within research studies as well as in
healthcare facilities.
The protection of human subjects during the course of research required permission for
academic institutions and clinical trials. All patient specific information was protected and
underwent re-coding where necessary to uphold patient privacy during the duration of the
research study. Approval from Walden IRB and HCUP privacy agreement use sustained and
presented no harm to the individual information provided by HCUP participants. The research
did not present any ethical issues for the university, Medicare, the researcher, or participants in
an effort to further determine gaps in previous related literature.
Threats to Validity
A critical threat to validity of the research study that had implications was the
misdiagnosis of hypertension for Medicare beneficiaries who were pre-hypertensive and those
who had infrequent occurrences of elevated blood pressure. The volume of patients who had a
prevalence of hypertension and had been medically diagnosed for a period of greater than 6
months provided more reliable data than beneficiaries who had elevated blood pressure readings
caused by stress, diet, exercise, or additional factors. An external factor that may have impacted
the validity of the research study was the absence of Medicare recipients who were classified as
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physically disabled, and were diagnosed as hypertensive. To safeguard against threats to
statistical validity, data representing a period of 4 years were utilized to permit a larger sample
size as well as the ability to exhibit possible variations within a given timeframe.
Summary
In summary, the quantitative research study was conducted to determine whether there
was a correlation between LOS and reimbursement rates for Medicare patients with
hypertension. The (HCUP) Nationwide database of the National Inpatient Sample (NIS) was
utilized as the secondary source for data. The secondary data source was converted to SPSS
which assisted in further analyzing the dependent and independent variables as well as applicable
covariates associated with the research study. The variables applied with the research were
relevant to place, time frame, and patient. The sample size of 398 for the time frame of 2011 to
2013 was calculated as a sufficient size to ensure and effective population size. The target
population for the research study was Medicare patients that were medically diagnosed with
hypertension within the United States. This size was determined by the calculations provided by
Open Source Epidemiologic Statistics for Public Health.
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Section 3: Research Results
Introduction
The objective of the research study was to determine whether there was a correlation
between the LOS and the rate of reimbursement among Medicare recipients with hypertension
while controlling for multiple covariates as listed in the research questions below.
RQ1 – Are reimbursement rates related to the LOS for Medicare patients with hypertension as
the reason for admission after controlling for geographic region, age, year, gender race/ethnicity,
and diabetes?
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
H2: The hospital reimbursement rate is not related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
RQ2 – Are the hospital reimbursement rates associated with prolonged hospitalization for
Medicare patients admitted for hypertension when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes?
H3: The hospital reimbursement rate is associated with prolonged hospitalization for Medicare
patients with hypertension as the reason for admission when controlling for geographic region,
age, year, gender, race/ethnicity, and diabetes.
H4: The hospital reimbursement rate is not associated with prolonged hospitalization for
Medicare patients with hypertension as the reason for admission when controlling for geographic
region, age, year, gender, race/ethnicity, and diabetes.
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Data Cleaning and Preprocessing
The initial sample size for the secondary data set was comprised of 22,440,121 cases for
three consecutive years (2011, 2012 & 2013) across the United States. The data set was filtered
by inclusion of the hypertensive Medicaid patients and further randomized to consist of 3,000
cases. The randomized results entailed a total of 197 missing cases for race/ethnicity. The 197
cases within the data set may have been attributed to patients having the option of not completing
documentation for race/ethnicity, or refusing to provide race/ethnicity information when
Medicaid status was provided. The exclusion of 197 cases of the 3,000 produced a 6.6%
omission factor for the cases to be analyzed, thus creating a very minimal impact. An additional
inclusion criterion was applied whereby patients needed to be a minimum of 18 years of age
because the research study was geared toward an aging population. Recoding for all variables
was utilized to formulate data with numeric measures for precise analysis.
Descriptive Statistics
The below table represents the descriptive statistical data output for the research study
utilizing the results for (N = 3,000) cases. The analysis encompassed the dependent variable of
LOS and the independent variable rate of reimbursement along with covariates that consisted of
age, gender, race/ethnicity, rate of reimbursement, year, region of the United States, and
diabetes. The dependent variable of LOS was divided into two categories of short duration and
long duration of hospital stay. The dependent variable of LOS was a dichotomous measure that
contained short and long hospitalization. The population of the research study encompassed
individuals with Medicare over the age of 18 who had been medically diagnosed as hypertensive.
Medicare patients who were not classified as physically handicapped or under the age of 18 were
excluded from the study.
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Table 4
Summary of Descriptive Statistics of LOS, Age, Gender, Reimbursement Rate, Race/Ethnicity,
Region, Diabetic, and Year for Medicare patients.
Variable

Characteristic

N = 3,000

LOS

0-3 days
>=4 days
18-65
66-85
>= 86
0 -25%
26-50%
51-75%
76-100%
Female
Male
White
Black
Hispanic
Asian
Other
South
Northeast
Mid-West
West
Yes
No
2011
2012
2013

1543
1457
1277
1299
424
755
732
734
779
1386
1614
1998
438
221
53
93
430
697
1676
197
2128
872
1371
1186
443

Age

Rate of
Reimbursement

Gender
Race/Ethnicity

Region

Diabetic
Year

Percentage

`

51.4%
48.6%
42.6%
43.3%
14.1%
25.2%
24.4%
24.5%
26.0%
46.2%
53.8%
71.3%
15.6%
7.9%
1.9%
3.3%
14.3%
23.2%
55.9%
6.6%
70.9%
29.1%
45.7%
39.5%
14.8%

Note: The data output for descriptive statistical analysis utilizing a sample size of 3,000 cases
and all variables.
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As show in the above descriptive table reflected 3 consecutive years, the data represents
the results of descriptive statistics (N = 3000). The dependent variable LOS was grouped into
two classifications of 0-3 days, and greater than or equal to 4 days. Approximately 51.4% (N =
1543) were hospitalized for 0-3 days, and 48.6% (N = 1457) hospitalized for 4 days or greater
over a three-year consecutive time frame. The variable age of Medicare patient was categorized
into three classifications that were 18-65 years included 42.36% (N = 1277) ; 66-85 years
included 43.3% (N = 1299); and greater than or equal to 86 years of age at 14.1% (N = 424).
The rate of reimbursement was categorized in 4 groups which consisted for low rate of
reimbursement 0-25%, moderately low 26-50%, moderately high 51-75%, and high rate of
reimbursement which consisted of 76-100% compensation. The low category of rate of
reimbursement applied to 25.2% of the participants (N = 755), the moderately low category
accounted for 24.4% (N = 732), moderately high applied to 24.5% (N = 734), and the high rate of
reimbursement applied to 26.0% (N = 779). Although rate of reimbursement appeared consistent
in calculations, the high rate of reimbursement was analyzed to be higher than the other three
categories.
Data for the variable gender indicated that females were represented at 46.2% of the
sample (N = 1386), while males represented a slightly higher percentage 53% (N = 1614). Data
for the variable race/ethnicity was classified into five groups. The variable ethnicity indicated
that 71.3% (N = 1998) were White; 15.6% (N = 438) were Black; 7.9% (N = 221) were Hispanic,
1.9% (N = 53) were Asian; and 14.3% (N = 93) were classified as other or missing
race/ethnicity. Region was categorized into four groups across the United States: South,
Northeast, Mid-West, and West. The Southern region represented 14.3% (N = 430) of the
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sample; Northeastern accounted for 23.2% (N = 697); Mid-Western accounted for 55.9% (N =
1676); and Western United States represented 6.6% (N = 197).
The research study also included the comorbidity of diabetes which accounted for 70.9%
(N = 2128) of which were diabetic, and 29.1% (N = 872) of the Medicare patients that were
hypertensive but not diabetic and hypertensive. The research study encompassed three
consecutive years of 2011, 2012, and 2013. In 2011 there were 45.7% (N = 1371) cases, in 2012
39.5% (N = 1186), and 2013 accounted for 14.8% (N = 443)
Two Way Tests of Association
Table 6
Summary of Two-Way Tests of Association Among LOS and Independent Variables
LOS
0-3 Days

Variable Category
Age

18-65

66-85

>=86

Total

>=4 Days

Pvalue

Total

Count
% with Age
% with LOS

719
56.3%
46.6%

558
43.7%
38.3%

1277
100%
42.6%

Count
% with Age
% with LOS

625
48.1%
40.5%

674
51.9%
46.3%

.000

1299
100%
43.3%

Count
% with Age
% with LOS

199
46.9%
12.9%

225
53.1%
15.4%

.001

424
100%
14.1%

Count
%with Age
% with LOS

1543
51.4%
100%

1457
48.6%
100%

3000
100%
100%

continued
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Count
% with ROR
% with LOS

LOS
0-3 Days
>=4 Days
602
153
79.7%
20.3%
39.0%
10.5%

PValue
.000

26-50%

Count
% with ROR
% with LOS

436
59.6%
28.3%

296
40.4%
20.3%

.000

732
100%
25.2%

51-75%

Count
% with ROR
% with LOS

306
41.7%
19.8%

428
58.3%
29.4%

.000

734
100%
24.5%

76-100%

Count
% with ROR
% with LOS

199
25.5%
12.9%

580
74.5%
39.8%

779
100%
26.0%

Count
% with ROR
% with LOS

1543
51.4%
100%

1457
48.6%
100%

3000
100%
100%

Male

Count
% with Male
% with LOS

822
50.9%
53.3%

792
49.1%
54.4%

1614
100%
53.8%

Female

Count
% with Female
% with LOS

721
52.0%
46.7%

665
48.0%
45.6%

Count
% with Gender
% with LOS

1543
51.4%
100%

1457
48.6%
100%

Variable Category
Rate of
0-25%
Reimbursement

Total

Gender

Total

.298

Total
755
100%
25.2%

1386
100%
46.2%
3000
100%
100%

continued
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Variable
Race/
Ethnicity

PValue

Count
% with LOS
% with Race

LOS
0-3 Days
>=4 Days
1018
980
71.2%
71.3%
51.0%
49.0%

Black

Count
% with LOS
% with Race

220
15.4%
50.2%

218
15.9%
49.8%

.965

438
15.6%
100%

Hispanic

Count
% with LOS
% with Race

124
8.7%
56.1%

97
7.1%
43.9%

.543

221
7.9%
100%

Asian

Count
% with LOS
% with Race

27
1.9%
50.9%

26
1.9%
49.1%

.502

53
1.9%
100%

Other

Count
% with LOS
% with Race

40
2.8%
43.0%

53
3.9%
57.0%

.926

93
3.3%
100%

Count
% with LOS
% with Race

1429
100%
51.0%

1374
100%
49.0%

2803
100%
100%

2011

Count
% with LOS
% with Year

691
44.8%
50.4%

680
46.7%
49.6%

1371
45.7%
100%

2012

Count
% with LOS
% with Year

626
40.6%
52.8%

560
38.4%
47.2%

.254

1186
39.5%
100%

2013

Count
% with LOS
% with Year

226
14.6%
51.0%

217
14.9%
49.0%

.025

443
14.8%
100%

Count
% with LOS
% with Year

1543
100%
51.4%

1457
100%
48.6%

Category
White

Total

Year

Total

Total
1998
71.3%
100%

3000
100%
100%

continued
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Variable
Region

PValue

Count
% with LOS
% with Region

LOS
0-3 Days
>=4 Days
214
216
13.9%
14.8%
49.8%
50.2%

Northeast

Count
% with LOS
% with Region

351
22.7%
50.4%

346
23.7%
49.6%

.864

697
23.2%
100%

Mid-West

Count
% with LOS
% with Region

928
60.1%
55.4%

748
51.3%
44.6%

.022

1676
55.9%
100%

West

Count
% with LOS
% with Region

50
3.2%
25.4%

147
10.1%
48.6%

.002

197
6.6%
100%

Count
% with LOS
% with Region

1543
100%
51.4%

1457
100%
48.6%

Yes

Count
% with LOS
% with Diabetes

1106
71.7%
52.0%

1022
70.1%
48.0%

No

Count
% with LOS
% with Diabetes

437
28.3%
50.1%

435
29.9%
49.9%

872
29.1%
100%

Count
% with LOS
% with Diabetes

1543
100%
51.4%

1457
100%
48.6%

3000
100%
100%

Category
South

Total

Diabetic

Total

Total
430
14.3%
100%

3000
100%
100%

.355

2128
70.9%
100%
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Table 6 represents the results of the two-way test of association among each independent
variable and the dependent variable LOS for short and long duration. Table 6 also displays the
p-value for each independent variable which serves as the indicator of the variable being
statistically significant or not statistically significant. The two-way tests encompassed a sample
size of (N = 3000) cases. The age category of 18-65 years had a short stay of 40.5% (N = 625)
and a long duration of 46.3% (N = 674) which yielded (p = .000) indicating that the variable was
statistically significant. The age range of 66-85 years had 46.6% (N = 719) of the highest
percentage in short duration of hospitalization among all age categories. The age category of
>=86 years yielded the lowest in short duration with 12.9% (N = 199) as well as long duration
with 14.1% (N = 424).
The rate of reimbursement, 0-25% chance of being reimbursed yielded the second highest
number of cases at 39% (N = 602). It also yielded a percentage in long duration category was
lower for patients with low reimbursement rate at 10.5% (N = 153). The highest rate of
reimbursement in the category of 76-100% yielded at 39.8% (N = 580) rate of reimbursement.
The category of 26-50% yielded 28.3% (N = 436) short duration and 51-75% produced 29.4% (N
= 428) for long duration. These results yielded a statistically significant (p-value = .000)
independent variable for the entire category.
The variable gender had two categories, female and male with a higher rate for both short
and long duration for males. The short duration for males was analyzed at 53.3% (N = 822),
with 54.4% (N = 792) for long duration. Females yielded 46.7% (N = 721) for short duration and
45.6% (N = 665) for long duration, producing a (p-value = .298) and indicating a variable that
was not statistically significant.
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The race/ethnicity variable was not statistically significant in no categories due to each pvalue being greater than .05. The white category had a considerable margin over the other races
at 71.2% (N = 1018) for short duration and 71.3% (N= 980) for long duration. The black
category for short duration was 15.4% (N = 220) and 15.9% (N = 218) for long duration. The
other races classified as Hispanic, Asian, and other were all less than 9% for both short and long
duration of hospital stay. The variable region was categorized into 4 groups that span across the
United States. South, Northeast, Mid-West, and West regions were all analyzed for short and
long duration which yielded a considerable difference among the Mid-West region at 60% (N =
928) for short duration and 51.3% (N = 748) for long duration. The Western region was at a
mere 3.2% (N = 50) for short duration and 10.1% (N = 147) for long duration making it the
lowest in both categories nationwide. These results yielded the Mid-West and West statically
significant with a (p-value = .022 and p-value = .002).
The diabetic variable generated 71.7% (N= 1106) for short duration and 70% (N = 1022)
for long duration indicating that approximately 72% of hypertensive Medicare patients were also
diabetic. While 28% (N = 437) short duration patients and 29.9% (N = 435) long duration
patients were not diabetic; however, hypertensive. The diabetic variable was not statistically
significant with a (p-value = .355). The calendar year variable of 2011 and 2012 yielded a
variable that was not statistically significant. The year 2011 yielded a 44.8% (N = 691) for short
duration and 46.7% (N = 680) for long duration placing it at the highest rate of hospital stay in
both categories during 2011. The year 2012 yielded results of 40.6% (N = 626) for short
duration and 38.4% (N = 560) for long duration ranking 2012 as the median for LOS for both
duration categories. The 2013 category was the lowest ranking year in both short and long
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duration with a 14.6% (N = 226) for short duration and 15% (N = 217) for long duration of
hospitalization being statistical significance (p-value = .025).

Multiple Logistic Regression Analysis
Table 7
Multiple Logistic Regression Analysis of Short Duration LOS and Long Duration LOS
(N = 3000)
Variable

Characteristic

Age

18-65
66-85
>= 86
0 -25%
26-50%
51-75%
76-100%
Female
Male
White
Black
Hispanic
Asian
Other
South
Northeast
Mid-West
West
Yes
No
2011
2012
2013

Rate of
Reimbursement

Gender
Race/Ethnicity

Region

Diabetic
Year

Adjusted Odds
Ratio
Reference
.724
1.547
.081
.236
.475
Reference
.915
Reference
Reference
1.221
.740
.923
1.495
Reference
1.025
.707
2.026
Reference
1.182
Reference
1.141
1.403

95% C.I.

P-Value

.604 - .868
1.195 - 2.003
.063 - .105
.187 - .298
.377 - .599

.000
.001
.000
.000
.000

.744 - 1.081

.298

.965 - 1.545
.543 - 1.008
.502 - 1.695
.926 - 2.412

.097
.056
.795
1.000

.724 - 1.357
.525 - .952
1.300 - 3.157

.864
.022
.002

.985 - 1.419

.072

.910 – 1.431
1.044 – 1.885

.254
.025
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Table 7 represents a multiple logistic regression model of the cases (N = 3000) which
illustrated the odds ratio, 95% confidence interval, and p-value. A multiple logistic regression
analysis was conducted to establish the correlation between dependent variable and the
independent variables while controlling for the covariates. The multiple logistic regression also
ascertained the presence of probability of the given output with specific percent. The dependent
variable LOS was dichotomous for short duration (recoded = 0) or long duration of stay (recoded
= 1). The following variables were not statistically significant: gender, year (2012),
race/ethnicity, region (northeast and south), and diabetes. The statistically significant variables
were age, rate of reimbursement, region (Mid-West, West), and the year (2013).
The variable age had a reference category of 18-65 years old that was primarily utilized
as a reference group due to a healthier age range of Medicare patients. The adjusted odds ratio in
66-85 years was .724 (p-value = .000) and (95% confidence interval range of .604 - .868),
yielding a statistically significant age category. The age range of 66-85 had an odds ratio of a
long stay which were lower for this age group compared to reference category. The age category
ranging >= 86 years had an adjusted odds ratio of 1.547 (p-value = .001) and (95% confidence
interval range of 1.195 – 2.003). This category age range was also statistically significant due to
the p-value and with a provided 1.547 chance more likely to have an extended hospitalization
than the reference group.
The reference group of 75-100 percentile was utilized for the rate of reimbursement. The
category of 0-25% yielded an adjusted odds ratio of .081 and (95% confidence interval range of
.063 - .105), making this category 91.9% lower odds of having a longer LOS than the highest
reimbursement category. The 51-75% category had an adjusted odds ratio of .475 (95%
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confidence interval range of .377 - .599), making this category 52.5% lower odds of having a
longer LOS than the reference group.
The variable region was statistically significant in the Mid-West and West regions. The
Mid-West region was statistically significant with a (p-value = .022) with an adjusted odds ratio
of .707 and (95% confidence interval of range of .525 - .952). The West region was statistically
significant with a (p-value = .002) and an adjusted odds ratio of 2.026 which presented greater
significance as compared with the reference group.
The variable year utilized 2011 as the reference group since it had the largest frequency
of (N = 1242). The variable year of 2013 generated an adjusted odds ratio of 1.403 (95%
confidence interval range of 1.044 – 1.885) with a statistically significant (p-value = .025),
yielding a greater significance as compared to the reference group. The year 2012 was not
statistically significant with a (p-value = .254). The adjusted odds ratio was 1.403 (95%
confidence interval range of .910 – 1.431), yielding a category with greater significance as
compared to the reference group.
Summary
The purpose of the descriptive analysis was to summarize the variables and
measurements within the research study with the use of quantitative analysis. The two-way test
of association was conducted to determine the relationship between the dependent and
independent variable. The objective of the multivariate logistic regression was to establish
which variables impacted to the LOS and determine the odds ratio, 95% confidence interval, and
the statistical significance of each variable. The age group with the largest ratio belonged to the
66-85 years old at 41% (N = 1216). The rate of reimbursement variable yielded consistency in
odds ratio, 95% confidence interval, and statistical significance which averaged around 23% (N
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= 700) among the 4 groups. The 95% confidence interval for the rate of reimbursement ranged
from (.063 to .599) for 3 categories and a (p-value = .000) for each category with the adjusted
odds ratio ranging (.081 to .475) as compared to the reference group.
Although gender was not statistically significant, the gender variable female had slightly
under 46.2% (N = 1386) with a .915% adjusted odds ratio compared to males. Females were
8.5% less likely to have longer hospitalization compared to the reference group. While the white
race/ethnicity had the bulk of cases as white with a frequency of 67% (N=1998), the
race/ethnicity variable did not have any statistically significant categories.
Only the Mid-West and Western regions had a statistical significance (p-value =.002 and
p-value = .022) in each region that may be attributed to geographic variation with in rural areas,
and in unplanned hospital admission rates. The odds ratio of the Mid-West region yielded .707
(95% confidence interval range of .525 - .952), producing a 29.3% lower odds of having a longer
LOS than the reference group. The West region yielded a 2.026 adjusted odds ratio with (95%
confidence interval range of 1.300 – 3.157), which produced greater significance as compared
with the reference group.
The comorbidity of diabetes did not have statistical significance or impact on the
correlation of LOS and the rate of reimbursement. The year variable presented significance in
2013 which yielded a (p-value = .025). Despite the multiple variables presented, none of the
variables eliminated the correlation between LOS and rate of reimbursement. Section 4 presents
the interpretation of findings, research study discussion, social change, and suggestions for
additional research.
The below first research question cannot be resolved due to the dependent variable LOS
not being provided within the secondary data set as a continual variable. Since the research
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question cannot be addressed due to the omission of a continuous LOS, a rejection or acceptance
of null or alternative hypothesis cannot be applied; therefore, the research question was removed.
RQ1 – Are reimbursement rates related to the LOS for Medicare patients with hypertension as
the reason for admission after controlling for geographic region, age, year, gender race/ethnicity,
and diabetes?
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
H2: The hospital reimbursement rate is not related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
Research question two direct variable LOS is categorical and significant; therefore, the
null hypothesis was rejected and the alternative hypothesis was accepted. The (p-value = .000)
presented significance between the dependent (LOS) and independent variable (rate of
reimbursement).
RQ2 – Are the hospital reimbursement rates associated with prolonged hospitalization for
Medicare patients admitted for hypertension when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes?
H3: The hospital reimbursement rate is associated with prolonged hospitalization for Medicare
patients with hypertension as the reason for admission when controlling for geographic region,
age, year, gender, race/ethnicity, and diabetes.
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H4: The hospital reimbursement rate is not associated with prolonged hospitalization for
Medicare patients with hypertension as the reason for admission when controlling for geographic
region, age, year, gender, race/ethnicity, and diabetes.
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Section 4: Discussion, Conclusion, and Recommendations
Overview
The purpose of this research study was to examine variations in LOS for Medicare
patients with hypertension and to provide an analytical explanation for the risk factors that have
been driving Medicare patients’ extended stay. The objective was also to explain the logic
behind costs applied for the duration of hospitalization and grasp concepts relevant to
standardizing reimbursement rates for Medicare recipients without placing limitations on
patients’ extended stay. The research involved further examination of cost-shift theory in
relation to Medicare reimbursement while simultaneously assisting in determining the variations
in current Medicare payment policies by state.
Interpretation of Findings
The quantitative outcome of the research study revealed that the statistically significant
variables were age, rate of reimbursement, region (Mid-West and West), and calendar year 2013.
The age category of 65-85 years displayed a greater odds ratio than the reference group which
was further explained by the onset age of 65 years for Medicare patients. Although, typically
people within the age range of 18-65 years may display a healthier population than the aging
patients from 65-85 years, extended stay rates for the latter were lower than the reference group.
The rate of reimbursement reference category of 0-25 percentile for 0-3 days had the greatest
amount of cases (N=602), however, the highest percentage of LOS was 39.8% in the >= 4 days
category. The category with the lowest percentage of extended stay was in the 0-25 percentile
with a 10.5% hospitalization, and a 20.3% rate of reimbursement for >= 4 days duration. The
rate of reimbursement was the highest in the 0-25 percentile at 79.7% which indicated that only a
quarter of reimbursements were paid by Medicare at nearly an 80% probability for the Medicare
patients who were hospitalized for 0-3 days. Although the goal for reimbursement rate is 100%
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compensation for short duration, only 25.5% are reimbursed; however, the >= 4 days category
for the 75 -100th percentile displayed 74.5%, which indicated that the rate of reimbursement for
longer duration had a greater probability of reimbursement.
The variable of region encompassed two categories that were statistically significant.
The Mid-West region contained the highest number of cases (N = 928) with a 60.1% LOS for 0-3
days duration. The >= 4 days category was comprised of 51.3% extended say which yielded the
longest duration in all regions. The West region yielded the lowest number of cases (N= 50) in
all regions with a 3.2% LOS for the 0-3 days category. The West region also consisted of the
longest extended stay within the region for the >= 4 days category at74.6%. The outcome for the
Mid-West and West regions may primarily be due to the geographic adjustment variations that
occur within regions that are not as densely populated. The results for the regions elucidated that
there are geographic variations among more rural states that permit a higher rate of
reimbursement as well as an extended length of hospitalization among Medicare hypertensive
patients.
The variable of year contained three categories, of which only 2013 was statistically
significant. The 0-3 days was comprised of (N = 226), which was nearly 15% of the total
population for the short duration. The extended stay for the 0-3 days category was 14.6% of (N
= 1543) for short duration, which was significantly lower than both 2011 and 2012 (44.8% &
40.6%). The >= 4 days category in 2013 yielded 14.8% of the (N = 1457) for percentage of
extended stay for long duration. Both short and long duration for the calendar year 2013 yielded
a total of (N = 443) cases out of the (N = 3000) at a 14.8% total LOS. The calendar year 2013
had the lowest amount of cases which can be attributed to the number of Medicare patients
which experienced a gradual decline in enrollees and beneficiaries.
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The variables such as race/ethnicity, gender, and diabetes were discovered to have no
impact on the rate of reimbursement or LOS for Medicare patients with hypertension as well as
no statistical significance. The findings of the research assisted in identifying gaps in the
literature concerning which factors impacted the rate of reimbursement and the LOS.
Geographic adjustment variations within the Mid-West and West regions played a significant
role in fluctuations among the dependent and independent variables; however, the correlation
between LOS and rate of reimbursement remained consistent despite the covariates that were
applied.
The significance of the research study provided an analytical explanation of the risk
factors that drive the rate of reimbursement and the LOS for Medicare patients with hypertension
by exposing variations such as geographic adjustments. The significance of the research study
also contributed a new viewpoint to previous and forthcoming research studies resources that
focus on Medicare patients’ hospital duration and the influence it has on Medicare’s rate of
reimbursement across each region of the United States. The findings of the research study also
integrated the literature review by further emphasizing the variations in reimbursement and
hospital duration for Medicare hypertensive patients as displayed in the analysis. Likewise, the
research study revealed the determinants of extended stay, and the influence on reimbursement
rates across four regions in the United States that were presented in the analysis. As in previous
research studies, the literature review incorporated extended hospitalization and rate of
reimbursement to have variations across different regions. More specifically, the Mid-West and
West regions exhibited the greatest variations as compared to the other regions. This was
primarily due to the geographic adjustment variations within rural regions that are customary for
Medicare reimbursement claims.
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The epidemiological triad model that was utilized was deemed necessary, in that it
provided a critical aspect of encompassing Medicare patients across the United States within the
timeframe of 2011 to 2013. The epidemiological framework was utilized to investigate
Medicare hypertensive patients and hospital outcomes in relation to rates of reimbursement.
More specifically, person was represented by Medicare patients, place was identified as 4
regions within the United States, and time was exhibited by the years 2011 to 2013. The triad
model implemented the LOS, person, place, and time frame for an effective approach illustrating
the interaction among the factors within the model. The conceptual framework directed
epidemiological exploration of variations in lengths of stay.
The research study and existing research studies were synthesized by exploring various
factors such as race, region, gender, age, comorbidities, Medicare reimbursement rates, and
yearly time frame to determine prolonged hospitalization for hypertensive Medicare patients.
The research correlation also sought out the national LOS and modifications that occurred with
the rate of reimbursement, and the analysis revealed that patients who were admitted typically
stayed 0-3 days unless multiple comorbidities were present. Medicare patients who were
hospitalized for >= 4 days displayed hypertension and additional health conditions such as
diabetes, renal failure, and congestive heart failure which were commonalities among
hypertensive patients. The research studies provided a response to an identified issue with
variations in Medicare reimbursement and LOS variations within the United States. This
research study has addressed where (Mid-West & West), what (geographic adjustments factors),
and why (estimations of operating expenses in rural regions) questions pertaining to variations in
reimbursement rates occur for hypertensive Medicare patients. The factors that were once
unknown in previous research have now been unearthed to address variations.
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Limitations of the Study
The limitations of the research included of omission of the dependent variable LOS not
having a continuous measure within the secondary data set. The secondary data set only
provided the dependent variable LOS to be analyzed as categorical, with the categories 0-3 days
and >= 4 days. Due to the omission of a continuous dependent variable, the below Research
Question 1 was not answered, and the researcher could not reject or accept the hypothesis or null
hypotheses. Therefore, the first research question could not be analyzed, and only leaving the
second research question to be analyzed and to address the significance of the research and
hypothesis.
RQ1 – Are reimbursement rates related to the LOS for Medicare patients with hypertension as
the reason for admission after controlling for geographic region, age, year, gender race/ethnicity,
and diabetes?
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
H2: The hospital reimbursement rate is not related to the LOS for Medicare patients with
hypertension as the reason for admission when controlling for geographic region, age, year,
gender, race/ethnicity, and diabetes.
Prior to the analysis of the secondary dataset, it was unknown that secondary data set
would have excluded a continuous direct variable prior to analyzing the data set. The unknown
factor was uncovered during the analysis and could not have been foreseen prior to internal
review board (IRB) approval. This exclusion impacted the research by reducing necessary
outcome data that may have addressed the reimbursement rates related to the LOS for Medicare
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patients with hypertension as the reason for admission after controlling for geographic region,
age, year, gender race/ethnicity, and diabetes.
Recommendations for Further Research
Further research could also encompass the mortality rate of hypertensive Medicare
patients. Hypertension-related mortality increased by 23% overall from 2000-2013 for both men
and women (Centers for Disease Control and Prevention, 2015). The mortality rate for men
within the age range of 45-64 years old displayed a 58.2% increase and 65-74 years exhibited a
16.5% increase with a statistically significant (p-value = .05). The mortality rate can be
incorporated within the existing covariates or perhaps replace covariates that were not
statistically significant within the research study.
An additional recommendation for further research would require isolation of geographic
regions to provide explicit populations from specific states and contrast the variations among an
itemized number of states. Identifying exact states may provide a researcher with the capability
to compare particular states that utilize geographic adjustments in rates of reimbursements as
well as target the number of days that hypertensive Medicare patients are being allotted for
hospitalization. State isolation would also permit a researcher to associate variations in Medicare
policies per state by examining differences in adjustments per region and state.
Geographic adjustments in Medicare reimbursement have been utilized within regions in
an effort to ensure that medical providers within rural areas are being fairly compensated
based on operating expenses within the region and state. By incorporating a more specific area
for analysis would also permit for a researcher to further examine reimbursement rates that
typically result in over or under payment for Medicare expenses. Future research could also
integrate variables such as primary payer, secondary insurance type, Medicare DRG coding, total
charges, and risk of mortality.
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Implication for Social Change
Implications for social change may deliver a foundation for policy reform by furnishing
analyzed data to Medicare and policy decision-makers to amend guidelines for reimbursement
rates and LOS. The social change could be methodologically significant because it may assist in
employing utilization of current ICD-10 codes, and this; may result in higher accuracy of
medical diagnosis than was seen prior to ICD-10. The research may assist in social change by
providing explanation for trends in Medicare lengths of stay. Likewise, the study may assist
healthcare administrators in standardizing reimbursement rates for Medicare recipients without
placing limitations on the patients’ LOS, and possibly improving patient outcomes.
The research may also be significant for social change because it could provide further
insight into the cost-shift theory for Medicare reimbursement while simultaneously assisting in
determining variations in current Medicare payment policies. These policies contain incentives
for healthcare to optimize reimbursement that may lead to efficient lengths of stay for Medicare
recipients. The implications could include unearthing the logic behind particular Medicare
states refusing to cover extended LOS, while LOS and reimbursement rates in other states
exhibit dramatic dissimilarities. The social change has the capability to be meaningful due to the
potential to reveal rationale for a government entity not being transparent across the board, as
well as to indicate whether there has been any improvement to decrease the fluctuations.
Furthermore, the research study may have implications for social change in that it may
lead to an even distribution of reimbursements which may alleviate medical and financial strain
on Medicare patients and their families. Medicare patients who reside in densely populated
areas may receive the same fair pricing, hospitalization, and reimbursements that those in rural
regions do.
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Conclusion
In summation, the research provides insight on rates of reimbursement across 4 regions,
indicating that the Mid-West and West regions of the United States utilizing geographic
adjustment variations. The adjustment variations have modified the rate of reimbursement as
well as the length of hospitalization in these two regions. Although, there is prevalence of
hypertension among Medicare patients in all regions, two regions were analyzed as having
higher rates of reimbursement and more appropriate LOS.
The correlation between the dependent variable LOS and the independent variable rate of
reimbursement remained consistent even after the covariates were applied during a two-way test
and a multiple regression analysis. Alleviating variations in reimbursements may not be a quick
process; however, applying uniform policies across the United States may assist in a more
strategic form of reimbursements. Lastly, the results of the research study may promote social
change through the application of equivalent charges, reimbursements, and LOS across all four
regions of the United States.
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Appendix A
Literature Matrix: LOS Results from Various Research Studies
Author/Year/Title

Sample

Variables

Maeda, et al, 2014
Variation in Hospital
Inpatient Prices Across
Small Geographic
Areas.

162
Counties
6 States

DV – Inpatient
pricing

Qureshi et al, 2013
Factors associated with
length of
hospitalization in
patients admitted with
transient ischemic
attack in United States

385

Mehta et al, 2016
Primary payer status,
individual patient
characteristics, and
hospital-level factors
affecting LOS and
total cost of
hospitalization in total
laryngectomy

4,128

IV –
Geographic
location

DV – LOS

Design
Multivariate
Analysis
Linear
Regression

Prices are significantly higher
for private vs. Medicare.
Payment policies from
Medicare affect private
payers. Public policy that
take into consideration
market-based approach or
payment reform to reduce
price variation

Multivariate
Analysis

Further strategies are required
to determine the reduction of
LOS

IV – Hospital
charges

DV – LOS

Findings

Multivariate
Analysis
IV – Total Cost Multi-linear
of
Regression
Hospitalization

The odds of being top
quartile of LOS for Medicaid
patients
by 41% compared to private
insured patients
After controlling for medical
factors Medicaid patients
had increased LOS
Overall cost was higher for
Medicaid and Medicare

74

Busby et al, 2015
A systematic review of
the magnitude and
cause of geographic
variation in unplanned
hospital admission
rates & LOS for
ambulatory care

43,819

DV – LOS
IV –
Admission
Rates

Crosssectional
Analysis

Wide variation in
admission rate
Fewer admission triggering
shorter LOS

(table continues)
Yoo et al, 2012
Effect of
Reimbursement
Reductions on Bone
Mineral Density
Testing for Female
Medicare Beneficiaries

1,320

Ku-Chou et al, 2012
Prediction of LOS of
First-Ever Ischemic
Stroke

330

Martinez-Martinez et
al, 2013
Transient ischemic
attacks clinics provide
equivalent and more
efficient care than
early in-hospital
assessment

211

Machnicki et al, 2011
Kidney transplant
Medicare payments
and LOS: associations
with comorbidities and
organ quality

27,594

DVCox
Reimbursement proportional
Reduction
hazard
regression
IV –
analysis
Supplemental
private health
insurance

Significant association
between reimbursement
reductions and decrease in
BMD test in female
Medicare beneficiaries
without supplemental
private insurance

DV- LOS
IV – clinical
predictors

Univariate
Analysis and
Multiple
Regression
Analysis

Severity of stroke revealed to
be a vital factor that
influences the LOS after a
cute stroke hospitalization

DV – Inpatient
Management

Logistic
regression

Transient ischemic attacks
clinics are efficient for the
early management of low- to
moderate-risk TIA patients
compared to in-hospital
assessment, with no higher
recurrence rates and at almost
one-fifth the cost.

Multi-linear
regression

Impact of comorbidities on
reimbursement, LOS and
transplant finances depend on
local practice, outcomes and
reimbursement system.
Further studies should be
conducted to confirm
associations and design
appropriate interventions

IV – Cost per
patient

DV- LOS
IV – Medicare
Payments

75
Burke et al, 2015
Characterizing
Pulmonary
Hypertension--Related
Hospitalization Costs
Among Medicare
Advantage

2,275

DVLinear
Readmission of regression
pulmonary
hypertension
hospitalization
IV – premature
mortality

PH-related hospitalizations
incur substantial healthcare
costs and require long
hospital stays for patients
with PAH. Improved
treatment approaches reduce
PAH disease progression
leading to costly and
burdensome inpatient stays
(table continues)

Ishak et al, 2012
Accounting for the
relationship between
per diem cost and LOS
when estimating
hospitalization costs

11,614

Canavan, 2013
Rehospitalization Is
Driving Costs in
Pulmonary Arterial
Hypertension

4,009

Sawant et al, 2013
Increased LOS and
costs associated with
inpatient management
of vascular access
failures

Singh et al, 2016
Emergency
Department and
Inpatient Healthcare
utilization due to
Hypertension.

DV- LOS

Linear
regression

Per diem costs are not
independent of LOS

Linear
regression

Overall, PAH who were
hospitalized during the study
period from January 2007
through December 2011,
39.2% were re-hospitalized
more than once.

Logistic
regression
analysis

Vascular access management
contributes to signiﬁcant
expenses especially during
ﬁrst few months of initiation
of dialysis. This increases
workload on the already
overburdened hospital
infrastructure and draws
up costs and increases length
of stay

Multivariableadjusted linear
or logistic
regression

Hypertension associated with
significant healthcare burden
in the U.S. Future studies
should assess strategies to
reduce hypertension-associated
cost and healthcare burden

IV – Per Diem
Costs

DV – LOS
IV –
Hospitalization
Costs

172

DV – LOS
IV - Costs

2,934,838 DV –
Hospitalization
outcomes
(LOS, charges,
disposition)
IVHypertension
associated ED

76

Suh et al, 2014
Effect of health
insurance type on
healthcare utilization
in patients with
hypertension: a
national health
insurance database

325,566

DV – LOS
IV –
Hospitalization
Costs

Logistic
regression

The pattern of higher
healthcare utilization among
MA patients persists even
after controlling for baseline
health conditions

